Market Insights Consumer OTC Pharmaceuticals

Cold & Cough Remedies - Worldwide

Worldwide

Revenue in the Cold & Cough Remedies market amounts to €39.55bn in 2024. The market is expected to grow annually by 6.40% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€10,380m in 2024).
In relation to total population figures, per person revenues of €5.11 are generated in 2024.

Key regions: India, Europe, Indonesia, Canada, Germany

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

In 2020, the Cold & Cough Remedies market witnessed a regression due to COVID-19-related restrictions. The regulations including lockdowns and remote working protected people from seasonal illness, leading to a reduction of the demand for cold and cough remedies. The growing awareness of hygiene during the COVID-19 pandemic further scales down the demand for cold and cough products. Nevertheless, some COVID-19-related symptoms are also quite similar to cold symptoms, which drives the market growth to some extent.

In the forecast period, the market is expected to generate higher revenues due to the growing share of the elderly population, who is more likely to get infected, and increased environmental pollution. The rising awareness of self-medication also plays an important role. The market is estimated at a CAGR of around 6% in the forecast period.

Methodology

The Cold & Cough Remedies market is built on resources from the Statista platform as well as on in-house market research, national statistical offices, international institutions, trade associations, companies, the trade press, and the experience of our analysts. We evaluate the status quo of the market, monitor trends, and create an independent forecast regarding market developments of the global Cold & Cough Remedies industry.